D-0516-2020 Class II Terminated
FDA drug recall D-0516-2020 was initiated by Integrated Health Concepts Inc. dba Conversio Health on November 12, 2019 and is designated Class II. Reason for recall: Lack of Processing Controls The recall status is terminated (terminated May 28, 2020). Affected quantity: N/A.
Recall Details
- Product Type
- Drugs
- Report Date
- November 27, 2019
- Initiation Date
- November 12, 2019
- Termination Date
- May 28, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Product Description
Albuterol 2.5mg / Ipratropium 0.75mg/ Triamcinolone 0.5 mg 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.
Reason for Recall
Lack of Processing Controls
Distribution Pattern
Nationwide in the U.S.
Code Information
All lots